CHRS

Coherus Oncology (CHRS)

About Coherus Oncology (CHRS)

Coherus Oncology, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of biosimilar therapeutics. Its products include UDENYCA and LOQTORZI. The company was founded by Dennis M. Lanfear, Stuart E. Builder, Dr. Alan Herman, Doug Farrar and Steve Glover in September 2010 and is headquartered in Redwood City, CA.

Details

Daily high

$1.40

Daily low

$1.32

Price at open

$1.38

52 Week High

$1.89

52 Week Low

$0.71

Market cap

168.0M

Dividend yield

0.00%

Volume

802,227

Avg. volume

998,548

P/E ratio

-.88

Coherus Oncology News